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Abstract: The synthesis and the evaluation as organocatalysts of new chiral guanidines derived
from benzimidazoles in the enantioselective α-amination of 1,3-dicarbonyl compounds using
di-t-butylazodicarboxylate as aminating agent is herein disclosed. The catalysts are readily synthesized
through the reaction of 2-chlorobezimidazole and a chiral amine in moderate-to-good yields. Among
all of them, those derived from (R)-1-phenylethan-1-amine (1) and (S)-1-(2-naphthyl)ethan-1-amine
(3) turned out to be the most efficient for such asymmetric transformation, rendering good-to-high
yields and moderate-to-good enantioselectivities for the amination products.
Keywords: organocatalysis; electrophilic amination; guanidines; asymmetric catalysis; dicarbonyl
compounds
1. Introduction
The synthesis of chiral molecules bearing a nitrogen-containing quaternary stereocenter adjacent
to a carboxylic acid derivative in a direct and catalytic manner is still considered a challenging
transformation [1–3]. Among the different strategies developed to accomplish this, the electrophilic
amination of 1,3-dicarbonyl compounds [4–7] has emerged as an attractive methodology. Since
the pioneering work developed by the Jørgensen group, who published a metal- [8] and an
organocatalyzed [9] amination of β-keto esters and β-keto nitriles with azodicarboxylates, the work
done in this field has grown considerably [10–15]. In the last years, the work developed in the field
of organocatalysis for this transformation has been quite prolific [16–20], especially thanks to the
irruption of the hydrogen-bond organocatalysis, which has resulted in the publication of several works
employing this strategy [21–29].
In the last decade, our research group has been involved in the synthesis and application of
benzimidazole-derivatives as bifunctional organocatalysts able to activate different 1,3-dicarbonyl
compounds through hydrogen-bond interactions in different asymmetric organocatalyzed
transformations [30–34]. Thus, although such benzimidazoles have recently demonstrated to be
efficient catalysts for the electrophilic amination of dicarbonyl compounds [35], we decided to further
extend the investigations in this difficult transformation by synthesizing new and readily available
guanidines derived from benzimidazoles and evaluating their catalytic performance (Figure 1).
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Figure 1. Benzimidazoles-based guanidine organocatalyst in the asymmetric electrophilic aminations 
of dicarbonyl compounds. 
2. Results and Discussion 
Firstly, a series of new different guanidine organocatalysts were synthesized following a 
straightforward methodology developed in our research group [30–35]. Thus, 2-chlorobenzimidazole 
was reacted with the corresponding chiral amine in the presence of Et3N (3 equiv.) at 200 °C (pressure 
tube) for 24 h (Figure 2). Under these conditions, the corresponding products (1–10) were obtained 
in moderate-to-good yields. As expected, lower yields were achieved when bulky aliphatic amines 
were employed (5–7). For the synthesis of benzimidazole 10, the corresponding 2-
chloromehtylbenzimidazole was used instead. 
 
Figure 2. Synthesis of chiral organocatalysts. 
Once the guanidine derivatives were synthesized, their performance as organocatalysts in the 
asymmetric electrophilic amination of 1,3-dicarbonyl compounds was evaluated. In the search for 
optimal conditions and catalyst, and based on our previous experience in this transformation [35], 
the reaction between ethyl 2-oxocyclopenthanecarboxylate and di-t-butylazodicarboxylate in toluene 
Figure 1. Benzimidazoles-based guanidine organocatalyst in the asymmetric electrophilic aminations
of dicarbonyl compounds.
2. Results and Discussion
Firstly, a series of new different guanidine organocatalysts were synthesized following a
straightforward methodology developed in our research group [30–35]. Thus, 2-chlorobenzimidazole
was reacted with the corresponding chiral amine in the presence of Et3N (3 equiv.) at 200 ◦C
(pressure tube) for 24 h (Figure 2). Under these conditions, the corresponding products (1–10)
were obtained in moderate-to-good yields. As expected, lower yields were achieved when bulky
aliphatic amines were employed (5–7). For the synthesis of benzimidazole 10, the corresponding
2-chloromehtylbenzimidazole was used instead.
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Once the guanidine derivatives were synthesized, their performance as organocatalysts in the
asymmetric electrophilic amination of 1,3-dicarbonyl compounds was evaluated. In the search for
optimal conditions and catalyst, and based on our previous experience in this transformation [35],
the reaction between ethyl 2-oxocyclopenthanecarboxylate and di-t-butylazodicarboxylate in toluene
at 25 ◦C was chosen as a model reaction using 10 mol % of guanidine-derivative loading (Table 1).
Thus, catalysts bearing an aromatic ring in the amine moiety (1–4) produced amination product 13a in
high conversions and good-to-high enantioselectivities (Table 1, entries 1–4), whereas those bearing an
aliphatic moiety (5–7) gave rise to 13a in low or moderate conversions and ee’s (Table 1, entries 5–7).
The influence of the hydrogens in the guanidine moiety was evaluated with catalyst 8 lacking one
of them and bearing a tertiary amine part. As can be observed, although the results were quite
good, the presence of an additional hydrogen—which could play an important role in the substrate
activation—seems to be crucial in order to achieve high conversions and enantioselectivities (Table 1,
entry 8). By the contrary, the introduction of an extra activation point by using an aminoalcohol moiety
as in catalyst 9 turned out to be detrimental for the reaction results (Table 1, entry 9). Catalyst 10 lacks
conjugation between nitrogens in the guanidine moiety, and gave rise to both low conversion and
enantioselection for compound 13a.
Table 1. Organocatalyst screening. a
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Entry Catalyst Conv. (%) b ee (%) c 
1 1 95 91 
2 2 90 66 
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4 4 96 78 
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7 7 22 Rac 
8 8 85 76 
9 9 40 10 
10 10 ~15 27 
a Unless otherwise stated, general conditions were 11a (0.15 mmol), 12 (1.1 equiv.), organocatalyst (10 
mol %) in toluene (1 mL) at 25 °C for 15 h. b Conversions determined by 1H-NMR from the crude 
reaction mixture. c Determined by chiral HPLC analysis (Daicel Chiralpak IA, see Experimental 
Section for details). 
According to the catalyst screening results, we decided to further optimize the reaction 
conditions with guanidine 1, since it performed the best in terms of both conversion and 
enantioselectivity for compound 13a. In this regard, the influence of the solvent, temperature, and 
catalyst loading was assessed (Table 2). As can be observed, although good conversions were 
reached, none of the solvents tested produced an amelioration in the enantioselectivity (Table 2, 
entries 1–4). Then, once toluene was selected as the optimal solvent, lowering the reaction 
temperature was the next parameter assayed. Thus, it was found that while ee barely changed at 0 
°C, the conversion dropped down to 87% (Table 2, entry 5). Finally, a decrease in the catalyst loading 
(5 mol %) was evaluated not only with catalyst 1 but also with 3, which also gave satisfactory results 
in the amination reaction. However, a slight drop in the enantioselectivity of the process was 
observed (Table 2, entries 6 and 7). 
  
Entry Catalyst Conv. (%) b ee (%) c
1 1 95 91
2 2 90 66
3 3 93 90
4 4 96 78
5 5 65 40
6 6 57 33
7 7 22 Rac
8 8 85 76
9 9 40 10
10 10 ~15 27
a Unless otherwise stated, general conditions were 11a (0.15 mmol), 12 (1.1 equiv.), organocatalyst (10 mol %)
in toluene (1 mL) at 25 ◦C for 15 h. b Conversions determined by 1H-NMR from the crude reaction mixture.
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According to the catalyst screening results, we decided to further optimize the reaction conditions
with guanidine 1, since it performed the best in terms of both conversion and enantioselectivity for
compound 13a. In this regard, the influence of the solvent, temperature, and catalyst loading was
assessed (Table 2). As can be observed, although good conversions were reached, none of the solvents
tested produced an amelioration in the enantioselectivity (Table 2, entries 1–4). Then, once toluene was
selected as the optimal solvent, lowering the reaction temperature was the next parameter assayed.
Thus, it was found that while ee bar ly chang at 0 ◦C, the c nversion dropp d down to 87% (Table 2,
entry 5). Finally, a decrease in the catalyst lo ding (5 mol %) was evaluated not only with catalyst 1
but also with 3, which also gave satisfactory results in the amination reaction. However, a slight drop
in the enantioselectivity of the process was observed (Table 2, entries 6 and 7).
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Entry Catalyst (x mol %) Solvent Temp. (°C) Conv. (%) b ee (%) c 
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4 1 (10 mol %) CH2Cl2 25 99 74 
5 1 (10 mol %) toluene 0 87 92 
6 1 (5 mol %) toluene 25 95 84 
7 3 (5 mol %) toluene 25 90 85 
a Unless otherwise stated, general conditions were 11a (0.15 mmol), 12 (1.1 equiv.), 1 or 3 (5 or 10 mol 
%) in the corresponding solvent (1 mL) at the corresponding temperature for 15 h. b Conversions 
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The influence of the substituent in the diazocompounds was also tested. In this regard, diethyl- 
and dibenzylazodicarboxylate were screened, but both of them gave rise to the corresponding 
amination products in lower yields and ee’s (see Supporting Information for details). 
After having screened several parameters, the optimal reaction conditions chosen were the use 
of benzimidazole 1 (10 mol %) as catalyst, toluene as solvent, and 25 °C as temperature. In addition, 
since catalyst 3 performed similarly to 1, it was also selected for testing the substrate scope of the 
reaction (Figure 3). Thus, cyclic five-membered 1,3-dicarbonyl compounds were firstly evaluated. As 
mentioned, good results were achieved for 13a. However, when substrates 11b and 11c were tested, 
the corresponding products 13b and 13c were only isolated in moderate-to-good yields and 
enantioselectivities [36]. Unfortunately, six-membered dicarbonyl compounds turned out to be 
unreactive under these conditions [36]. Next, indanone-derived β-keto esters were assayed. As can 
be observed in Figure 2, increasing the steric bulk at the alkyl substituent of the ester moiety resulted 
in lower enantioselectivities and yields, obtaining the best enantioselection for methyl ester 
derivative 13f (60% ee). As somehow expected, the more-reactive 2-acetyl-1-indanone gave rise to the 
amination product 13j in moderate enantioselectivity, although in unexpectedly slightly lower yield 
than its keto ester analogue. Next, tetralone derivatives were taken into account. Contrary to the 
behavior observed with their non-benzocondensed analogues, very high enantioselectivities were 
achieved along with good yields. Again, 13k, bearing a methyl ester moiety, was superior in terms of 
ee in front of 13l (85% and 80% ee, respectively with catalyst 1). Lower yields and enantioselectivities 
were obtained for product 13m when the more reactive diketone was employed, being the drop even 
more accused in this case. Finally, open-chained 1.3-keto esters—which normally fail with most of 
the published catalysts [35]—were assayed. To our surprise, the use of ethyl benzoyl acetate gave rise 
to the corresponding amination product in good ee’s, although with poor yields. Despite this, 
encouraged by the good enantioselectivities reached for 13n we decided to test another acyclic 
ketoester: methyl 3-oxo-2-methylbutanoate. Disappointingly, the reaction failed completely with 
both catalysts. It is important to mention that with the aim of obtaining better results a decrease in 
reaction temperature was assayed in the majority of the cases where compounds 13 were achieved 
with moderate ee’s and good yields. However, with the exception of compound 13j, where the ee 
increased significantly, no substantial enhancement of optical purity was observed and, in addition, 
a drop in the yield was observed in most cases. 
Entry Catalyst (x mol %) Solvent Temp. (◦C) Conv. (%) b ee (%) c
1 1 (10 mol %) toluene 25 95 91
2 1 (10 mol %) hexane 25 97 85
3 1 (10 mol %) Et2O 25 99 70
4 1 (10 mol %) CH2Cl2 25 9 74
5 1 (10 mol %) toluene 0 87 92
6 1 (5 mol %) toluene 25 95 84
7 3 (5 mol %) toluene 25 90 85
a Unless otherwise stated, general conditions were 11a (0.15 mmol), 12 (1.1 equiv.), 1 or 3 (5 or 10 mol %) in the
corresponding solvent (1 mL) at the corresponding temperature for 15 h. b Conversions determined by 1H-NMR
from the crude reaction mixture. c Determined by chiral HPLC analysis (Daicel Chiralpak IA, see Experimental
Section for details).
The influence of the substituent in the diazocompounds was also tested. In this regard, diethyl-
and dibenzylazodicarboxylate were screened, but b th of them gave rise to the cor esponding
minatio products in l wer yields and e ’s (see S pporting Infor ation for details).
After having screened sev ral parameters, the optimal reaction c ditions chosen were the use
of benzimid zole 1 (10 mol %) as cat lyst, toluene as solvent, nd 25 ◦C as temperature. In addition,
sinc catalyst 3 performed similarly to 1 it was also selected for testing the substrat scope of the
rea tion (Figure 3). Thus, cycl c five-membered 1,3-dicarbonyl compounds were firstly evalua ed.
As me tioned, good results were achieved for 13a. However, when substrates 11b and 11c were
tested, the c rresponding products 13b and 13c r only isolated in moderate-to-good yiel s
and enantioselectivities [36]. Unfortunately, six-membered dicarbonyl compounds turn d out to
be unreactive under these condi io s [36]. Next, indanone-derived β-keto esters were assayed. As can
be obser d in Figure 2, increasi g the steric bulk t th alkyl substituent of the est r moiety resulted
in l w enantioselectivities and yields, obtaining the b st enantio election or m thyl ester derivative
13f (60% ee). As s mehow expecte , th more-react ve 2-acetyl-1-inda one gave rise to the amination
product 13j in mod rate enantioselectivity, alt ough in unexpectedly slightly l wer yi ld than its
keto ester analogue. Next, tetralon derivatives were taken into account. Contrary to the b havior
observed with their on-benzocond nsed analogues, very high enantiosele tivities were achieved
along with good yields. Agai , 13k, bearing a methyl ester moi t , was superior in terms of ee in
front of 13l (85% and 80% ee, respectively with c talyst 1). Low r yields and en ntios lectiviti s were
obtained f r product 13m when the more reactive dike one was emplo ed, bei g the drop ven more
accused in this case. Finally, open-chained 1.3-ke o sters—which normally fail with most of the
published catalys s [35]—were assayed. To our surpris , the use of ethyl benzoy acetate gave ri e to
corresponding amination product in good ee’s, although with poor yields. Despite this, encouraged
by g od ena tioselectivities reached for 13n we d cided t test anot er acycl c ketoester: met yl
3-oxo-2-methylbutan ate. Disappointingly, the reaction failed completely with both ca alysts. It s
impor ant to mention that with the aim f obtaining better resul s a decrease in r acti n temperature
was assayed in the majori y of the cases where compounds 13 were achiev d with moderate e ’s and
good yields. However, with the exception of comp und 13j, wher the ee increased significantly, no
substantial enhancement f optical purity was observed and, in additi n, a drop in the yi ld was
observ in most cases.
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In order to gain a deeper knowledge about the reaction mechanism, nonlinear effect experiments
were conducted to determine whether one or more catalyst molecules are involved in the catalytic
cycle [37]. According to the observed results, it was deter i ed that such a nonlinear effect
did not occur in the s udied reaction, pointi g towards the involvement of a single catalyst
molecule oper ting in the catalytic ycle (see Supporting Information for d tails about the
experiments). Thus, a hypothetical model for the catalytic cycle is d picted in Figure 4, which
is based on previous computational and experimental studies carried out in our research group
employing benzimidazole-derived catalysts in asymmetric conjugate additions. Thus, guanidine
benzi idazole-derived (R)-1 could act as a bifunctional organocatalyst, acting initially as a base.
Then, the 1,3-dicarbonyl compound enolate formed could be coordinated with the organocatalyst
through hydrogen bonding, as depicted in intermediate A. A possible pi–pi stacking interaction would
explain the good results observed in the benzocondensed β-keto esters, and could not be ruled out.
Afterwards, the protonated guanidine group can activate the azodicarboxylate and hence facilitate
the enantioselective attack of the enolate (intermediate B), releasing the corresponding amination
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product and regenerating (R)-1. It is important to remark that (R)-configured amination product was
obtained when (R)-1 is employed. This assumption was taken by comparison of experimental evidence
(chiral HPLC charts and optical rotation) with those previously reported in the literature for the same
products. As expected, when (S)-3 was the catalyst employed, the opposite absolute configuration was
observed in the amination product.
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procedures [19,22,35]. IRs were recorded on a JASCO FT-IR 4100 LE (Pike Miracle ATR) (Jasco 
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spectra were performed on a Bruker AC-300 or Bruker Avance-400 400 (Bruker Corporation, Billerica, 
MA, USA) using CDCl3 as solvent and tetramethylsilane (TMS) as internal standard unless otherwise 
stated. Low-resolution electron impact (EI) mass spectra were obtained at 70 eV on Agilent GC/MS-
5973N apparatus equipped with a HP-5MS column (Agilent technologies, 30 m × 0.25 mm). Optical 
rotations were measured on a JASCO P-1030 Polarimeter (Jasco Analítica Spain, Madrid, Spain) with 
a 5 cm cell (c given in g/100 mL). Enantioselectivities were determined by HPLC analysis (Agilent 
1100 Series HPLC) equipped with a G1315B diode array detector and a Quat Pump G1311A (Agilent 
Technologies, Santa Clara, CA, USA) equipped with the corresponding Daicel chiral column, and the 
retention time of the major enantiomer is highlighted in bold. Analytical thin layer chromatography 
(TLC) was performed on Merck silica gel plates and the spots visualized with UV light at 254 nm 
(Merck Millipore, Billerica, MA, USA). Flash chromatography employed Merck silica gel 60 (0.040–
0.063 mm) (Merck Millipore). 
3.1. General Procedure for the Synthesis of Benzimidazole-Based Organocatalysts 1–10 
In a sealed pressure tube, a mixture of 2-chloro-1H-benzo[d]imidazole (0.5 mmol), the 
corresponding chiral amine 1 (2.5 equiv.), and Et3N (3 equiv.) was heated at 195–200 °C during 24 h. 
The reaction mixture was then allowed to reach room temperature. After the addition of H2O (5 mL), 
the mixture was extracted with CH2Cl2 (3 × 5 mL). The combined organic phases were dried over 
MgSO4 and evaporated under reduced pressure to give the corresponding crude products, which 
were purified by flash chromatography (Hexane/EtOAc/MeOH). For the synthesis of benzimidazole 
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3. Materials and Methods
All reagents were purchased from commercial sources and used without further purification.
Substrates that were not commercially available were synthesized according to known literature
procedures [19,22,35]. IRs were recorded on a JASCO FT-IR 4100 LE (Pike Miracle ATR) (Jasco
Analítica Spain, Madrid, Spain), and only the structurally most relevant peaks are listed. NMR spectra
were performed on a Bruker AC-300 or Bruker Avance-400 400 (Bruker Corporation, Billerica, MA,
USA) using CDCl3 as solvent and tetramethylsilane (TMS) as internal standard unless otherwise stated.
Low-resolution electron impact (EI) mass spectra were obtained at 70 eV on Agilent GC/MS-5973N
apparatus equipped with a HP-5MS column (Agilent technologies, 30 m × 0.25 mm). Optical rotations
were measured on a JASCO P-1030 Polarimeter (Jasco Analítica Spain, Madrid, Spain) with a 5 cm cell
(c given in g/100 mL). Enantioselectivities were determined by HPLC analysis (Agilent 1100 Series
HPLC) quipped with a G1315B diode a ray detector and a Quat Pump G1311A (Agilent Technologies,
Santa Clara, CA, USA) equipped with the corresponding Daicel chiral column, and he retention
time of the major enantiomer is highlighted in bold. Anal tical thin layer chromatography (TLC)
was performed on Merck silica gel plates and the spots visualized with UV light at 254 nm (Merck
Millipore, Billerica, MA, USA). Flash chromatography employed Merck silica gel 60 (0.040–0.063 mm)
(Merck Millipore).
3.1. General Procedure for the Synthesis of Benzimidazole-Based Org noc alys s 1–10
In a sealed pressure tube, a mixture of 2-chloro-1H-benzo[d]imidazole (0.5 mmol), the corresponding
chiral amine 1 (2.5 equiv.), and Et3N (3 equiv.) was heated at 195–200 ◦C during 24 h. The reaction
mixtur was th n allowed to re ch oom temperature. Aft r the addition of H2O (5 mL), the mixture
was extracted with CH2Cl2 (3 × 5 mL). The combined organic phases were dried over MgSO4 and
Molecules 2017, 22, 1333 7 of 11
evaporated under reduced pressure to give the corresponding crude products, which were purified
by flash chromatography (Hexane/EtOAc/MeOH). For the synthesis of benzimidazole 10, the same
procedure was followed using 2-chloromethylbenzimidazole (0.5 mmol). The data shown below
correspond to the pure compounds:
(R)-N-(1-Phenylethyl)-1H-benzo[d]imidazol-2-amine (1): White powder; [α]D26 = +78.0 (c = 0.75, CHCl3);
IR (ATR) νmax: 3412, 3059, 1565, 1463, 1271, 1133, 1012 cm−1; 1H-NMR (300 MHz, CDCl3) δH = 1.45 (d,
J = 6.8 Hz, 3H), 5.00 (q, J = 6.8 Hz, 1H), 6.14 (s, 1H), 7.05 (dd, J = 5.8, 3.2 Hz, 2H), 7.14–7.30 (m, 7H)
ppm; 13C-NMR (75 MHz, CDCl3) δC = 24.0, 52.9, 112.3, 120.6, 125.7, 127.3, 128.7, 144.0, 155.1 ppm; MS
(EI) m/z 237 (M+, 53%), 138 (100), 105 (65), 77 (17).
(R)-N-(1-(2-Methoxyphenyl)ethyl)-1H-benzo[d]imidazol-2-amine (2): White powder; [α]D28 = +67.6 (c = 1.01,
CHCl3); IR (ATR) νmax: 3395, 3054, 2963, 1576, 1463, 1258, 1131 cm−1; 1H-NMR (300 MHz, CDCl3)
δH = 1.44 (d, J = 6.7 Hz, 3H), 3.35 (s, 3H), 5.34 (m, 1H), 6.02–6.42 (s, 1H), 6.63 (d, J = 8.2 Hz, 1H), 6.81 (t,
J = 7.4 Hz, 1H), 6.96 (m, 2H), 7.14 (m, 3H), 7.25 (m, 1H), 11.05–9.14 (br s, 1H) ppm; 13C-NMR (75 MHz,
CDCl3): δC = 22.3, 49.0, 54.8, 110.7, 112.1, 120.2, 120.8, 126.5,128.3, 131.6, 155.2, 156.5 ppm; MS (EI) m/z
267 (M+, 25%), 236 (57), 135 (100), 105 (25), 77 (13).
(S)-N-(1-(Naphthalen-2-yl)ethyl)-1H-benzo[d]imidazol-2-amine (3): Yellowish powder; [α]D25 = −105.5
(c = 1.00, CHCl3); IR (ATR) νmax: 3392, 3053, 1600, 1571, 1462, 1268, 1130 cm−1; 1H-NMR (300 MHz,
CDCl3) δH = 1.51 (d, J = 6.7 Hz, 3H), 4.95 (d, J = 6.6 Hz, 1H), 6.03 (s, 1H), 6.96 (dd, J = 5.7, 3.2 Hz, 2H),
7.16 (dd, J = 5.7, 3.0 Hz, 2H), 7.34–7.47 (m, 3H), 7.60–7.79 (m, 4H), ppm; 13C-NMR (75 MHz, CDCl3) δC
= 24.0 53.3, 112.3, 120.6, 124.0, 124.1, 125.9, 126.3, 127.6, 127.8, 128.8, 132.8, 133.3, 141.1, 154.6, ppm.
(R)-N-(1-(Naphthalen-1-yl)ethyl)-1H-benzo[d]imidazol-2-amine (4): Yellowish powder; [α]D23 = −95.5
(c = 0.99, CHCl3); IR (ATR) νmax: 3405, 3050, 1572, 1462, 1268 cm−1;1H-NMR (300 MHz, CDCl3)
δH = 1.42 (d, J = 6.7 Hz, 3H), 5.56 (q, J = 6.3 Hz, 1H), 6.09 (s, 1H), 6.86–6.93 (m, 2H), 7.03 (s, 2H),
7.15–7.31 (m, 3H), 7.41 (d, J = 7.0 Hz, 1H), 7.66 (m, 1H), 7.85 (d, J = 8.5 Hz, 1H) ppm. 13C-NMR (75 MHz,
CDCl3) δC = 22.6, 49.1, 120.3, 122.0, 122.8, 125.4, 125.6, 126.1, 128.0, 128.8, 130.6, 133.9, 139.0, 154.7 ppm.
(R)-N-(2,3-Dihydro-1H-inden-1-yl)-1H-benzo[d]imidazol-2-amine (5): Light brown powder; [α]D26 = +18.2
(c = 0.75, CHCl3); IR (ATR) νmax: 3043, 2936, 1578, 1461, 1270, 1054 cm−1; 1H-NMR (300 MHz, CDCl3)
δH = 1.83–1.98 (m, 1H), 2.59–2.72 (m, 1H), 2.78–2.91 (m, 1H), 2.92–3.04 (m, 1H), 5.07–5.31 (br s, 1H),
5.39 (t, J = 7.1 Hz, 3H), 7.02–7.09 (m, 2H), 7.12–7.20 (m, 1H), 7.22–7.26 (m, 2H), 7.26–7.37 (m, 3H) ppm;
13C-NMR (75 MHz, CDCl3) δC = 30.0, 34.3, 58.5, 112.1, 120.9, 123.9, 124.9, 126.7, 128.1, 142.8, 143.1,
154.3 ppm; MS (EI) m/z 249 (M+, 27%), 133 (100), 115 (44), 91 (10).
(R)-N-(1-Cyclohexylethyl)-1H-benzo[d]imidazol-2-amine (6): White powder; [α]D26 = +2.7 (c = 0.98, CHCl3);
IR (ATR) νmax: 3390, 2924, 2851, 1630, 1577, 1463, 1262, 1156 cm−1; 1H-NMR (300 MHz, CDCl3)
δH = 0.77–1.09 (m, 5H), 1.12 (d, J = 6.6 Hz, 3H), 1.29–1.40 (m, 1H), 1.50–1.66 (m, 5H), 3.81 (m, 1H), 5.38
(s, 1H), 7.01 (dd, J = 5.8, 3.2 Hz, 2H), 7.25 (dd, J = 6.1, 2.9 Hz, 2H) ppm; 13C-NMR (75 MHz, CDCl3)
δC = 18.3, 26.1, 26.3, 28.7, 29.0, 43.3, 53.6, 111.9, 120.4, 129.8, 137.8, 155.8 ppm; MS (EI) m/z 243 (M+,
24%), 200 (8), 160 (59), 133 (100), 105 (9).
(R)-N-(3,3-Dimethylbutan-2-yl)-1H-benzo[d]imidazol-2-amine (7): White powder; [α]D28 = −69.6 (c = 0.97,
CHCl3); IR (ATR) νmax: 3054, 2931, 1628, 1572, 1461, 1239, 1027 cm−1; 1H-NMR (300 MHz, CDCl3)
δH = 0.79 (s, 9H) 1.08 (t, J = 11.8 Hz, 3H),3.80 (s, 1H), 5.31 (s, 1H), 7.01 (dt, J = 10.2, 5.1 Hz, 2H), 7.25 (td,
J = 6.1, 2.6 Hz, 2H) ppm; 13C-NMR (75 MHz, CDCl3) δC = 16.7 26.1, 34.4, 57.4, 111.9, 120.4, 156.4 ppm;
MS (EI) m/z 217 (M+, 22%), 223 (100), 133 (17), 105 (4).
(S)-N-Methyl-N-(1-phenylethyl)-1H-benzo[d]imidazol-2-amine (8): White powder; [α]D27 =−177.6 (c = 1.00,
CHCl3); IR (ATR) νmax: 2975, 1559, 1506, 1418, 1264, 1030, 905 cm−1; 1H-NMR (300 MHz, CDCl3)
δH = 1.51 (d, J = 6.9 Hz, 3H), 2.79 (s, 3H), 5.64 (q, J = 7.0 Hz, 1H), 7.11 (m, 9H) ppm; 13C-NMR (75 MHz,
CDCl3) δC = 16.2, 30.6, 55.7, 112.2, 120.4, 126.9, 127.4, 128.6, 140.7, 156.3 ppm; MS (EI) m/z 251 (M+,
86%), 236 (48), 147 (100), 118 (44), 105 (85), 91 (11), 77 (23).
Molecules 2017, 22, 1333 8 of 11
(R)-2-[(1H-Benzo[d]imidazol-2-yl)amino]-2-phenylethanol (9): White powder; [α]D29 = −83.0 (c = 0.71,
MeOH); 1H-NMR (300 MHz, CD3COD) δH = 3.80 (dd, J = 11.3, 6.9 Hz, 1H), 3.88 (dd, J = 11.3, 4.8 Hz,
1H), 4.08 (q, 1H), 6.90–6.97 (m, 2H), 7.13–7.25 (m, 3H), 7.27–7.37 (m, 4H), 7.41–7.47 (m, 2H) ppm;
13C-NMR (75 MHz, CD3COD) δC = 24.0, 52.8, 112.2, 120.5, 125.6, 127.3, 128.7, 143.9, 155.0.
(R)-N-((1H-Benzo[d]imidazol-2-yl)methyl)-1-phenylethanamine (10): White powder; [α]D28 = −22.6
(c = 1.00, CHCl3); IR (ATR) νmax: 3052, 1424, 1264 cm−1; 1H-NMR (300 MHz, CDCl3) δH = 1.37
(d, J = 6.6 Hz, 3H) 3.80 (q, 1H), 3.90 (2H), 5.35–6.00 (s, 1H), 7.17–7.23 (m, 3H), 7.24–7.29 (m, 3H),
7.31–7.36 (m, 1H), 7.49–7.57 (m, 2H) ppm; 13C-NMR (75 MHz, CDCl3): δC = 23.9,45.3, 58.1, 76.6, 77.1,
77.5, 114.9, 122.4, 126.6, 127.3, 128.6, 138.3, 144.2, 153.9.
3.2. General Procedure for the Asymmetric Amination of 1,3-Dicarbonyl Compounds
In an open-air tube at room temperature (25 ◦C) the corresponding 1,3-dicarbonyl compound
(0.1 mmol) was added to a solution of organocatalyst (0.01 mmol, 10 mol %) in toluene (1 mL).
After 5 min, di-tert-butylazodicarboxilate (0.11 mmol, 1.1 equiv.) was added in one portion and the
reaction was then allowed to react for 15 h. After this time, water (5 mL) and ethyl acetate were added,
and then the aqueous layer was re-extracted twice (2 × 10 mL). The combined organic phases were
dried (MgSO4) and evaporated under reduced pressure. Finally, the reaction crude was purified by
column chromatography on silica gel or preparative TLC using hexane/ethyl acetate mixtures as
eluent. The analytical data shown below correspond to those enantioenriched products (≥20% ee)
as representative compounds. All the compounds are described in the literature. Therefore, only
1H-NMR, MS (EI) and enantiomeric excess determination conditions are listed.
(R)-Di-tert-butyl 1-[1-(ethoxycarbonyl)-2-oxocyclopentyl]hydrazine-1,2-dicarboxylate (13a) [35]: Colorless
oil; [α]D28 = −6.10 (c = 0.49, CHCl3, 91% ee); 1H-NMR (300 MHz, CDCl3) δH = 1.28 (t, J = 7.1 Hz,
3H), 1.59–1.36 (m, 18H), 2.98–1.75 (m, 6H), 4.24 (m, 2H), 6.53 (br s, 1H) ppm; chiral HPLC analysis:
Chiralcel IA column, Hexane/EtOH 96:04, flow rate = 0.7 mL/min, λ = 210 nm, retention times: 9.9
and 11.0 min.
(R)-Di-tert-butyl 1-(3-acetyl-2-oxotetrahydrofuran-3-yl)hydrazine-1,2-dicarboxylate (13b) [35]: Colorless oil;
[α]D28 = +2.64 (c = 1.0, CHCl3, 50% ee); 1H-NMR (300 MHz, CDCl3) δH = 1.47 (d, J = 1.9 Hz, 18H), 1.62
(s, 3H), 2.28–2.44 (m, 2H), 4.38 (d, J = 6.6 Hz, 2H), 6.79 (br s, 1H) ppm; chiral HPLC analysis: Chiralcel
IA column, Hexane/EtOH 98:02, flow rate = 1 mL/min, λ = 210 nm, retention times: 21.0 and 24.2 min.
(R)-Di-tert-butyl 1-(1-acetyl-2-oxocyclopentyl)hydrazine-1,2-dicarboxylate (13c) [35]: Colorless oil; [α]D28 =
+16.99 (c = 1.1, CHCl3, 43% ee); 1H-NMR (300 MHz, CDCl3) δH = 1.45 (d, J = 7.2 Hz, 18H), 1.56–2.09 (m,
3H), 2.51–2.18 (m, 5H), 2.84–2.51 (m, 1H), 6.48 (br s, 1H) ppm; chiral HPLC analysis: Chiralcel AD-H
column, Hexane/EtOH 98:02, flow rate = 1 mL/min, λ = 210 nm, retention times: 12.2 and 17.3 min.
(R)-Di-tert-butyl 1-[2-(methoxycarbonyl)-1-oxo-2,3-dihydro-1H-inden-2-yl]hydrazine-1,2-dicarboxylate
(13f) [24]: Slightly yellow oil; [α]D28 = −57.19 (c = 1.0, CHCl3, 60% ee); 1H-NMR (300 MHz, CDCl3)
δH = 0.78–1.89 (m, 18H), 3.45–4.39 (m, 5H), 6.34–6.84 (m, 1H), 7.36 (t, J = 7.4 Hz, 1H), 7.49 (d, J = 7.2 Hz,
1H), 7.63 (t, J = 7.2 Hz, 1H), 7.77 (d, J = 7.6 Hz, 1H) ppm; chiral HPLC analysis: Chiralcel IA column,
Hexane/iPrOH 90:10, flow rate = 1 mL/min, λ = 240 nm, retention times: 16.1 and 22.1 min.
(R)-Di-tert-butyl 1-[2-(ethoxycarbonyl)-1-oxo-2,3-dihydro-1H-inden-2-yl]hydrazine-1,2-dicarboxylate
(13g) [35]: Colorless sticky oil; [α]D28 = −42.40 (c = 1.4, CHCl3, 55% ee); 1H-NMR (300 MHz, CDCl3)
δH = 1.14–1.55 (m, 21H), 3.82 (d, J = 16.6 Hz, 1H), 3.96–4.32 (m, 3H), 6.31–6.83 (bs, 1H), 7.36 (t, J = 7.3 Hz,
1H), 7.49 (d, J = 6.9 Hz, 1H), 7.62 (t, J = 7.2 Hz, 1H), 7.76 (d, J = 9.4 Hz, 1H) ppm; chiral HPLC analysis:
Chiralcel IA column, Hexane/iPrOH 90:10, flow rate = 1 mL/min, λ = 240 nm, retention times: 12.5
and 14.4 min.
(R)-Di-tert-butyl 1-(2-(isopropoxycarbonyl)-1-oxo-2,3-dihydro-1H-inden-2-yl)hydrazine-1,2-dicarboxylate
(13h) [29]: Colorless oil; [α]D28 = −6.46, (c = 1.4, CHCl3 29% ee); 1H-NMR (300 MHz, CDCl3)
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δH = 1.12–1.52 (m, 24H), 3.71 (dd, J = 69.4, 16.6 Hz, 1H), 4.16 (m, 1H), 5.03 (dt, J = 12.4, 6.1 Hz,
1H), 6.32–6.83 (m, 1H), 7.35 (t, J = 7.2 Hz, 1H), 7.49 (d, J = 7.6 Hz, 1H), 7.61 (t, J = 7.2 Hz, 1H), 7.74 (d,
J = 14.7 Hz, 1H) ppm; chiral HPLC analysis: Chiralcel AD-H column, Hexane/EtOH 96:04, flow rate =
1 mL/min, λ = 254 nm, retention times: 11.2 and 28.5 min.
(R)-Di-tert-butyl 1-(2-(tert-butoxycarbonyl)-1-oxo-2,3-dihydro-1H-inden-2-yl)hydrazine-1,2-dicarboxylate
(13i) [29]: Colorless oil; [α]D28 = −3.20, (c = 1.0, CHCl3, 21% ee); 1H-NMR (300 MHz, CDCl3)
δH = 1.55–1.21 (m, 27H), 3.22 (d, J = 17.2 Hz, 1H), 3.65 (d, J = 17.2 Hz, 1H), 6.62 (br s, 1H), 7.36
(d, J = 7.4 Hz, 1H), 7.48 (d, J = 7.7 Hz, 1H), 7.59–7.69 (m, 1H), 7.79 (d, J = 7.2 Hz, 1H); chiral HPLC
analysis: Chiralcel AD-H column, Hexane/EtOH 96:04, flow rate = 1 mL/min, λ = 254 nm, retention
times: 10.4 and 18.4 min.
Di-tert-butyl 1-(2-acetyl-1-oxo-2,3-dihydro-1H-inden-2-yl)hydrazine-1,2-dicarboxylate (13j) [35]: Slightly
yellow oil; [α]D28 = +41.70, (c = 1.0, CHCl3, 57% ee); 1H-NMR (300 MHz, CDCl3) δH = 1.38 (br m, 18H),
2.35 (m, J = 39.1 Hz, 3H), 3.58 (m, 1H), 4.15 (m, 1H), 6.82 (br s, 1H), 7.34 (d, J = 6.7 Hz, 1H), 7.49 (d,
J = 7.0 Hz, 1H), 7.63 (m, 2H) ppm; chiral HPLC analysis: Chiralcel IA column, Hexane/iPrOH 90:10,
flow rate = 1 mL/min, λ = 240 nm, retention times: 19.3 and 24.3 min.
(S)-Di-tert-butyl 1-[2-(methoxycarbonyl)-1-oxo-2,3-dihydro-1H-tetralone-2-yl]hydrazine-1,2-dicarboxylate
(13k) [24]: Slightly yellow oil; [α]D28 = +6.07 (c = 1.2, CHCl3, 87% ee); 1H-NMR (300 MHz, CDCl3)
δH = 1.20–1.26 (m, 8H), 1.47 (s, 11H), 2.53–3.09 (m, 4H), 3.82 (s, 3H), 6.22 (br s, 1H), 7.36 (d, J = 6.0 Hz,
1H), 7.45 (d, J = 6.9 Hz, 1H), 7.69 (d, J = 8.3 Hz, 1H), 7.91 (d, J = 7.3 Hz, 1H) ppm; chiral HPLC analysis:
Chiralcel OD-H column, Hexane/iPrOH 95:05, flow rate = 1 mL/min, λ = 240 nm, retention times:
15.8 and 17.7 min.
(R)-Di-tert-butyl 1-[2-(ethoxycarbonyl)-1-oxo-2,3-dihydro-1H-tetralone-2-yl]hydrazine-1,2-dicarboxylate
(13l) [35]: Slightly yellow sticky oil; [α]D28 = −11.53 (c = 1.2, CHCl3, 80% ee); 1H-NMR (300 MHz,
CDCl3) δH = 1.26–1.47 (br m, 21H), 2.67 (dd, J = 16.3, 6.5 Hz, 1H), 2.95 (d, J = 17.4 Hz, 2H), 3.44 (br s,
1H), 4.23–4.35 (m, 2H), 6.21 (m, 1H), 7.26 (d, J = 8.1 Hz, 2H), 7.45 (t, J = 7.2 Hz, 1H), 7.89 (d, J = 7.6 Hz,
1H) ppm; chiral HPLC analysis: Chiralcel AD-H column, Hexane/iPrOH 85:15, flow rate = 1 mL/min,
λ = 240 nm, retention times: 8.6 and 11.4 min.
(R)-Di-tert-butyl 1-(2-acetyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)hydrazine-1,2-dicarboxylate (13m) [35]:
Dark brown oil; [α]D28 = −8.23, (c = 1.1, CHCl3, 27% ee); 1H-NMR (300 MHz, CDCl3) δH = 1.52–1.43
(m, 18H), 2.41 (m, 3H), 2.70 (br s, 2H), 3.13–2.85 (m, 2H), 6.21 (s, 1H), 7.19 (d, J = 7.8 Hz, 1H), 7.30 (d,
J = 3.7 Hz, 1H), 7.46 (t, J = 7.4 Hz, 1H), 7.97 (d, J = 7.7 Hz, 1H) ppm; chiral HPLC analysis: Chiralcel IA
column, Hexane/iPrOH 90:10, flow rate = 1 mL/min, λ = 240 nm, retention times: 19.5 and 22.6 min.
Di-tert-butyl 1-(1-ethoxy-2-methyl-1,3-dioxo-3-phenylpropan-2-yl)hydrazine-1,2dicarboxylate (13n) [38]: Not
isolated; 1H-NMR (300 MHz, CDCl3) δH = 1.71–1.19 (m, 24H), 4.33 (dd, J = 7.0, 3.1 Hz, 2H), 6.51–5.92
(br s, 1H), 7.56–7.43 (m, 3H), 8.53 (m, 2H) ppm; chiral HPLC analysis: Chiralcel AD-H column,
Hexane/iPrOH 90:10, flow rate = 1 mL/min, λ = 210 nm, retention times: = 8.5 and 17.9 min.
4. Conclusions
In summary, in this work we have described the synthesis and application of new chiral guanidines
derived from benzimidazoles as organocatalysts for the asymmetric electrophilic α-amination of
1,3-dicarbonyl compounds employing di-t-butylazodicarboxylate as aminating agent. In general,
the new catalysts are synthesized in good yields in a straightforward one-step reaction. In addition,
the amination products were obtained in good yields and enantioselectivities varying from moderate
to high when 10 mol % of catalysts 1 and 3 were employed. Although a more comprehensive study
about the reaction mechanism is necessary, a bifunctional role of the catalyst is postulated.
Supplementary Materials: General remarks and NMR copies of representative catalysts as well as 1H-NMR and
HPLC charts of amination compounds are provided.
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